151 related articles for article (PubMed ID: 30078718)
21. Anti-α
Fiore M; d'Oiron R; Pillois X; Alessi MC
Br J Haematol; 2018 Apr; 181(2):173-182. PubMed ID: 29611179
[TBL] [Abstract][Full Text] [Related]
22. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
Valentino LA
J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
[TBL] [Abstract][Full Text] [Related]
23. Detection of transfused platelets in a patient with Glanzmann thrombasthenia.
Nurden A; Combrié R; Nurden P
Thromb Haemost; 2002 Mar; 87(3):543-4. PubMed ID: 11916093
[No Abstract] [Full Text] [Related]
24. Perioperative management of a patient with Glanzmann thrombasthenia undergoing a coronary artery bypass graft surgery: a case report.
Kurdi M; Frère C; Amour J; Brumpt C; Delort J; Lebreton G; Croisille L; d'Oiron R; Martin-Toutain I
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):327-329. PubMed ID: 29474205
[TBL] [Abstract][Full Text] [Related]
25. Acquired Glanzmann thrombasthenia associated with platelet desialylation.
Zheng SS; Perdomo JS; Leung HHL; Yan F; Chong BH
J Thromb Haemost; 2020 Mar; 18(3):714-721. PubMed ID: 31869497
[TBL] [Abstract][Full Text] [Related]
26. Glanzmann thrombasthenia: a rare hematological disorder with oral manifestations: a case report.
Ranjith A; Nandakumar K
J Contemp Dent Pract; 2008 Jul; 9(5):107-13. PubMed ID: 18633476
[TBL] [Abstract][Full Text] [Related]
27. Glanzmann Thrombasthenia: A Clinicopathological Profile.
Iqbal I; Farhan S; Ahmed N
J Coll Physicians Surg Pak; 2016 Aug; 26(8):647-50. PubMed ID: 27539755
[TBL] [Abstract][Full Text] [Related]
28. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
Levy-Mendelovich S; Levy T; Budnik I; Barg AA; Rosenberg N; Seligsohn U; Kenet G; Livnat T
Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
[TBL] [Abstract][Full Text] [Related]
29. Successful ovariectomy in a dog with Glanzmann thrombasthenia.
Brdecka DJ; Adin CA; Boudreaux MK; Crawford EC; Randall SR
J Am Vet Med Assoc; 2004 Jun; 224(11):1796-8, 1788. PubMed ID: 15198264
[TBL] [Abstract][Full Text] [Related]
30. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
Balci YI; Karabulut A; Kabukcu S; Sari I; Keskin A
Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms.
Mutreja D; Sharma RK; Purohit A; Aggarwal M; Saxena R
Indian J Med Res; 2017 May; 145(5):629-634. PubMed ID: 28948953
[TBL] [Abstract][Full Text] [Related]
32. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
[TBL] [Abstract][Full Text] [Related]
33. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
34. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
Di Minno G; Coppola A; Di Minno MN; Poon MC
Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.
Eghbali A; Melikof L; Taherahmadi H; Bagheri B
Haemophilia; 2016 Sep; 22(5):e423-6. PubMed ID: 27478149
[TBL] [Abstract][Full Text] [Related]
36. Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpression.
Hu L; Du L; Zhao Y; Li W; Ouyang Q; Zhou D; Lu G; Lin G
Stem Cell Res; 2017 Apr; 20():14-20. PubMed ID: 28232155
[TBL] [Abstract][Full Text] [Related]
37. [Glanzmann thrombasthenia and pregnancy--report of a case and literature review].
Uchikova E; Pechlivanov B; Parahuleva N; Amaliev G
Akush Ginekol (Sofiia); 2014; 53(5):49-51. PubMed ID: 25558673
[TBL] [Abstract][Full Text] [Related]
38. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
39. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
40. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
Kale A; Bayhan G; Yalinkaya A; Yayla M
J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
